课题基金 / 基金详情

Dissemination & Translation Core

Dissemination & Translation Core
传播
批准号:
7456108
负责人:
KATHERINE A JONES
金额:
$3.42万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-06-30

项目摘要

项目成果

KATHERINE A JONES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of the Dissemination and Translation (D&T) Core is to develop, implement, and evaluate activities to disseminate and translate research results in a timely fashion to stakeholders in the scientific, clinical, and policy communities. The difference between translation strategies and more traditional dissemination methods can be seen in the following definitions:39 Dissemination - the active promulgation of the findings of good quality research evidence and promotion or support of their use in practice and policy. Translation - the process of adapting, modifying, or re-inventing an intervention that has been previously tested and found efficacious to make it workable in a practice setting. Selected implementation strategies to promote behavior change are applied. The specific target groups for SMART Center dissemination and translation activities will be determined by the level and strength of evidence that has been generated by completed, core and pilot studies. Results from completed and core studies may be ready for translation into practice and to inform health care policy; results of pilot studies and smaller core studies may be appropriate for dissemination to other center scientists, other centers on campus, and the scientific community at large.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
WNT TARGET GENE REGULATION BY BETA-CATENIN AND THE APC TUMOR SUPPRESSOR
  • 批准号:
    8365827
  • 项目类别:
  • 资助金额:
    $1.28万
  • 财政年份:
    2011
  • 负责人:
    KATHERINE A JONES
  • 依托单位:
Mechanism of beta-catenin and APC-regulated transcription of Wnt target genes
Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes
Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data